Compare HROW & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | DV |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | N/A | 2021 |
| Metric | HROW | DV |
|---|---|---|
| Price | $40.64 | $10.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 17 |
| Target Price | ★ $68.86 | $16.59 |
| AVG Volume (30 Days) | 579.2K | ★ 2.1M |
| Earning Date | 03-16-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | $250,042,000.00 | ★ $733,324,000.00 |
| Revenue This Year | $38.57 | $17.87 |
| Revenue Next Year | $42.17 | $10.36 |
| P/E Ratio | ★ N/A | $41.14 |
| Revenue Growth | ★ 47.83 | 14.86 |
| 52 Week Low | $20.85 | $7.64 |
| 52 Week High | $54.85 | $23.11 |
| Indicator | HROW | DV |
|---|---|---|
| Relative Strength Index (RSI) | 31.23 | 45.77 |
| Support Level | $44.55 | $10.62 |
| Resistance Level | $44.05 | $11.23 |
| Average True Range (ATR) | 2.08 | 0.32 |
| MACD | -0.96 | 0.02 |
| Stochastic Oscillator | 1.26 | 51.03 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.